Bio Pharma Dive
JANUARY 21, 2022
After halting a Phase 3 trial of the drug last year, Roche went digging for more data. What it found led to plans for another trial, but the pharma's hypothesis may rest on shaky ground.
World of DTC Marketing
JANUARY 21, 2022
Omnichannel is the latest buzzword-making rounds within pharma, but omnichannel has no relevance if your message is too promotional or is irrelevant to your audience. The channel IS essential but not as important as your message. 68% of HCPs indicate webinars or webcasts as their most preferred channel to receive information. It is evident that HCPs are extremely time constraint and prefer to engage with pharma organizations on their terms regarding channel, content, and type of devices.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 21, 2022
New results show the effects of its next drug for transthyretin amyloidosis appear to hold up for a year and a half. But it's unclear whether treatment will help those with heart problems, a much larger market opportunity.
Pharma Times
JANUARY 21, 2022
Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology enables the measurement of disease-indicating molecules in extremely low concentrations–in ten minutes or less.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
JANUARY 21, 2022
A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron. Details of the study were published in The Lancet this week. UCLH researchers stated that antibodies generated in people who had received only two doses of either the Oxford/AstraZeneca vaccine or the Pfizer/BioNTech vaccin
Pharma Times
JANUARY 21, 2022
New figures from Health Education England (HEE) show that the pharmacist vacancy rate in community pharmacies across England has doubled to 8% between 2017 and 2021.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
JANUARY 21, 2022
The US Food and Drug Administration (FDA) has approved not one, but two, new orally administered drugs for the treatment of moderate to severe eczema (atopic dermatitis), which include AbbVie’s Rinvoq (upadacitinib) and Pfizer’s Cibinqo (abrocitinib). While Rinvoq was approved for eczema patients 12 years of age and older, Pfizer’s Cibinqo was approved for use in adults only.
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for NAPROXEN+SODIUM Naproxen Sodium is a drug marketed by Bionpharma Inc, Catalent, Puracap Pharm Llc, Actavis Labs Fl Inc, Able, Amneal Pharms Ny, Aurobindo Pharma Ltd,…. The post New patent for Bionpharma Inc drug NAPROXEN SODIUM appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 21, 2022
Mange has decimated the population of wild vicuñas and guanacos in an Argentinian national park that was created to conserve them, according to a study from the Administration of National Parks in Argentina and the University of California, Davis. Credit: Hebe del Valle Ferreyra Mange has decimated the population of wild vicuñas and guanacos in […].
Drug Channels
JANUARY 21, 2022
Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Chris discusses how COVID-19 is impacting stakeholders across the healthcare system, including patients, providers, pharmacies, and manufacturers. On February 22nd at 1:00 pm ET, ConnectiveRx will host Four Big Implications for Patients and the Prescription Journey in 2022 , a free webinar about the pandemic’s impact on key healthcare stakeholders.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
JANUARY 21, 2022
In 2021, NASA technology saved 330 lives in the U.S. network region of the international satellite-aided search and rescue effort, Cospas-Sarsat. NASA has lent technical expertise to the Cospas-Sarsat program since its founding, aiding in the rescue of over 48,000 individuals globally. Credit: NOAA In 2021, NASA technology saved 330 lives in the U.S. network region […].
pharmaphorum
JANUARY 21, 2022
The US regulator has granted biliary tract cancer therapy Silmitasertib orphan drug designation. There are currently no treatments for this rare cancer, and the US food and Drug Administration (FDA) hopes that pharmaceutical firm Senhwa’s drug will meet the significant need for new biliary tract cancer options. First-line standard of care is currently a chemotherapy regimen of gemcitabine and the powerful intravenous drug cisplatin However, there are no globally accepted standards of care for lo
Scienmag
JANUARY 21, 2022
While both patients and clinicians prioritize information transparency, a 21st Century Cures Act requirement for the immediate release of test and lab results is proving more controversial, according to recently published survey results of clinicians and patients. The study, published recently in The American Journal of Surgery, found that of the clinicians surveyed, nearly 63% agreed that immediately released […].
pharmaphorum
JANUARY 21, 2022
Japan’s health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five and 11. The vaccine, Comirnaty, is claimed to be the first in Japan to be approved for use in this age group. Once the Ministry of Health, Labor and Welfare grants special approval, Japan will join the UK and US in efforts to reduce the impact of COVID-19 in children.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
JANUARY 21, 2022
Sinuous stellar jets meander lazily across a field of stars in new images captured from Chile by the international Gemini Observatory, a Program of NSF’s NOIRLab. The gently curving stellar jets are the outflow from young stars, and astronomers suspect their sidewinding appearances are caused by the gravitational attraction of companion stars.
pharmaphorum
JANUARY 21, 2022
As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.
Scienmag
JANUARY 21, 2022
Renowned immunologists and vascular biologists Drs. Klaus Ley and Catherine “Lynn” Hedrick from California’s La Jolla Institute for Immunology have been named co-directors of the new Center for Immunology at the Medical College of Georgia at Augusta University, an initiative which will dramatically expand research to better harness the power of the immune system to […].
Drug Discovery World podcast
JANUARY 21, 2022
This is the latest episode of the free DDW podcast, “From here to there: What lies ahead for drug discovery”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW and read aloud by Megan Thomas. The articles are called “The complexity of disease biology gives opportunities for drug discovery” and “The human touch: the benefits of real-world evidence”.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
JANUARY 21, 2022
A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2. Credit: Veesler Lab A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are nine patents protecting this drug. INVELTYS drug…. The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 21, 2022
Polymer materials are used in every part of our life – from textile fibers to automotive engineering. Due to their functional properties like strength, durability, low weight, and many others, they are frequently applied in biomedicine. One such functional polymers are hydrogels capable of holding large amounts of water. Depending on the chemical formula, these polymers can change […].
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. There are twelve patents protecting this drug. EYSUVIS drug…. The post New patent for Kala Pharms drug EYSUVIS appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
JANUARY 21, 2022
Industry and private consumers alike depend on oil and gas pipelines that stretch thousands of kilometers underwater. It is not uncommon for these pipelines to become clogged with deposits. Until now, there have been few means of identifying the formation of plugs in-situ and non-destructively. Measurements at the Research Neutron Source Heinz Maier-Leibnitz (FRM II) […].
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for GOCOVRI Gocovri is a drug marketed by Adamas Pharma and is included in one NDA. It is available from one supplier. There are seventeen patents…. The post New patent for Adamas Pharma drug GOCOVRI appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 21, 2022
KNOXVILLE, Tenn. – A program within the University of Tennessee Institute of Agriculture has been recognized as the nation’s leading educator of high school agriculture teachers. Credit: Image courtesy UTIA. KNOXVILLE, Tenn. – A program within the University of Tennessee Institute of Agriculture has been recognized as the nation’s leading educator of high school agriculture […].
Drug Patent Watch
JANUARY 21, 2022
Annual Drug Patent Expirations for JUBLIA Jublia is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…. The post New patent for Bausch drug JUBLIA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
JANUARY 21, 2022
Recent breakthroughs in multiple fields of study now allow researchers to follow the entire life cycle of ocean fishes—from when and where they are spawned, to where they disperse and grow, to when and where they are captured, transported, and eaten. Credit: Shawn Heinrichs/ Conservation International Recent breakthroughs in multiple fields of study now allow […].
XTalks
JANUARY 21, 2022
Prior to the COVID-19 pandemic, food trade shows helped small and large businesses alike attract new buyers and customers. But when the pandemic struck, physical stores, in-person exhibitions and expos came to a halt. Fortunately, online technology and tools came to the rescue and e-commerce blossomed. . Like many global industries, the multi-trillion-dollar global food and beverage industry was severely disrupted by the pandemic.
Scienmag
JANUARY 21, 2022
COLUMBIA, Mo. — While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection. Credit: MU College of Veterinary Medicine COLUMBIA, Mo. — While the Omicron variant continues to infect people around the world, […].
pharmaphorum
JANUARY 21, 2022
Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. Balancing the incentivisation of innovation against affordable access to revolutionary new medicines is an age-old conundrum in the biopharmaceutical industry. And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccin
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
339 
Let's personalize your content